Featured Research

from universities, journals, and other organizations

Ohio State Chemists Synthesize Possible New Anti-Tumor Agent

Date:
May 4, 2001
Source:
Ohio State University
Summary:
Using a frothy brew of soil bacteria as a guide, chemists at Ohio State University have synthesized a substance that may lead to a new generation of chemotherapy drugs.

COLUMBUS, Ohio - Using a frothy brew of soil bacteria as a guide, chemists at Ohio State University have synthesized a substance that may lead to a new generation of chemotherapy drugs.

Related Articles


Laboratories around the world have struggled to create a synthetic version of the chemical, called azinomycin A, ever since it was discovered in bacteria in 1986. The natural form of the chemical breaks down too quickly for scientists to test whether it could be used to combat cancer cells in the body.

Now that Ohio State researchers have completed their quest to build an exact copy of azinomycin A atom by atom, they can try to redesign the chemical into a stable, medically usable form, said Rob Coleman, professor of chemistry at Ohio State and principal investigator of the project.

This research, which was funded by the National Cancer Institute, appears in the current issue of the German chemistry journal Angewandte Chemie. The journal issue, dated May 5, 2001, is set to appear on the World Wide Web at on May 2, 2001, at http://www.angewandte.com.

"More important than synthesizing the agent is what we've learned along the way," Coleman said. "We need to understand the chemical mechanisms behind azinomycin A so that we can develop more effective anti-tumor agents in the future."

Coleman said an enhanced version of azinomycin A might make an especially potent chemotherapy agent. He pointed to laboratory tests from 1987, when Japanese scientists found that the short-lived natural version of the chemical attacked tumor cells in a test tube and was effective as combating cancer in animal models.

Scientists now believe azinomycin A and its sibling azinomycin B -- both produced by a type of Streptomyces soil bacteria - attack DNA by forming very strong bonds, and are two of only a handful of chemicals that bond to DNA in this way.

In 1989, Coleman first began to design the chemical steps needed to synthesize azinomycin A and B in the laboratory. He started the work at the University of South Carolina and, beginning in 1996, at Ohio State.

Over that time, several researchers contributed to the project. In particular, Coleman credits Andrew Carpenter and Thomas Richardson, both his former Ph.D. students, and Jian-She Kong, an Ohio State postdoctoral researcher in chemistry, with performing important preliminary studies. The Ohio State work in the Angewandte Chemie paper was done by Coleman's co-authors, Jing Li and Antonio Navarro, both postdoctoral researchers.

Coleman and his colleagues devised a strategy for breaking the complex-shaped azinomycin A molecule into five smaller pieces. Over 11 years, the researchers performed essentially all possible series of chemical reactions these constituents could undergo, starting over whenever they reached a chemical dead end.

The researchers charted each chemical reaction like a composer would write a score for a symphony orchestra, Coleman said: "We had to write every note for every instrument, think about how the different instruments would play off each other."

To obtain natural azinomycin A for comparison, they fermented a broth of Streptomyces bacteria, which Coleman says resembles a good Irish ale, and isolated both of the azinomycins.

In February 2001, the researchers obtained the synthetic form of azinomycin A that perfectly matched the original. "For all intents and purposes, they are absolutely indistinguishable," Coleman said.

Now the Ohio State researchers are investigating how azinomycin A and B form such strong bonds with DNA. They have also started tinkering with the synthetic formula.

"We think we're beginning to see why the natural form is unstable, and that gives us some idea of where to go next with building new anti-tumor agents," Coleman said.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Ohio State Chemists Synthesize Possible New Anti-Tumor Agent." ScienceDaily. ScienceDaily, 4 May 2001. <www.sciencedaily.com/releases/2001/05/010504083432.htm>.
Ohio State University. (2001, May 4). Ohio State Chemists Synthesize Possible New Anti-Tumor Agent. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2001/05/010504083432.htm
Ohio State University. "Ohio State Chemists Synthesize Possible New Anti-Tumor Agent." ScienceDaily. www.sciencedaily.com/releases/2001/05/010504083432.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins